iStride™ Device

We are currently running paid clinical trials for the iStride™ Device. Find out more info here! .

  • US Patent No. 9295302
  • This device when worn by a patient having a hemiparetic gait (a gait where one side is impaired) helps those patients relearn a more normal gait.
  • The iStride™ Device, which is in its clinical trial, is an ‘overshoe’ that a person straps to their sneaker on their good leg, which causes the foot to move backwards when a person puts weight on the foot. This helps stroke patients relearn how to walk with a normal symmetric gait, by among other things, causing an increased reliance and speed of motion of the paretic leg.
  • The device reproduces some of the effects of the split-belt while allowing the user to learn in the environment where he or she naturally walks.
  • The iStride™ Device, developed by Dr. Kyle Reed and his team at the University of South Florida, became one of the leading university gait research laboratories in the world.
  • The iStride™ Device (originally called GEMS) was successfully used in first clinical trial.


The Future
The iStride™ Device will be paired with electronics, which will grant patients and caretakers the ability to track progress and some day may allow changes to the device to be controlled remotely. We also plan to have an iStride™ Device community aspect to the electronic pairing so that families and therapists can see how the patient is doing, and so the patient can chat with other iStride™ Device users around the world to encourage support on the journey towards relearning to walk.

We design, develop, and test high impact products in the field of mobility and rehabilitation

Our projects arise from recognizing the unsolved problems of mobility challenged people.  We solve these problems with new technology that we develop to help you and your family live full lives. Our company is focused on sourcing, designing, engineering, manufacturing and selling the highest quality products to significantly impact people through addressing the problems of stroke rehabilitation and other chronic neural disorders.

Currently we have made a next generation device, which is currently being tested in a home based trial, for which we are actively recruiting participants.